Viz.ai, a frontrunner in artificial intelligence (AI) powered disease detection and intelligent care coordination, has inked an exclusive agreement with the University of California, San Francisco (UCSF) to commercialize three AI algorithms. Developed by leading researchers at UCSF, these algorithms aim for the automated detection of cardiovascular diseases, including cardiac amyloidosis, pulmonary hypertension, and supraventricular […]
NurOwn phase 3 trial : BrainStorm Cell Therapeutics, a US biotech company engaged in developing adult stem cell therapies for neurodegenerative diseases, has completed the dosing of all the participants in a phase 3 trial of NurOwn (MSC-NTF cells) in amyotrophic lateral sclerosis (ALS). The late-stage trial enrolled nearly 200 participants, who have been randomized […]
Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. The preclinical testing will be carried out in laboratories at the University of California in Davis (UC Davis). Verndari, which was established in 2015, is said to have developed the […]
